Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 7661 Download: 90 Web of Science: 7 Crossref: 7

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 7745 Download: 84 Web of Science: 2 Crossref: 2

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 8308 Download: 82 Web of Science: 14 Crossref: 11

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9296 Download: 88 Web of Science: 13 Crossref: 12

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir

Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim

Clin Mol Hepatol. 2015;21(1):24-31. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.24

View: 8664 Download: 109 Web of Science: 14 Crossref: 14

Review

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 8378 Download: 138 Web of Science: 18 Crossref: 17

Original Article

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong

Clin Mol Hepatol. 2014;20(4):355-360. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.355 Correction in: Clin Mol Hepatol 2015;21(1):104

View: 7803 Download: 76 Web of Science: 6 Crossref: 7

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2014;20(4):347-354. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.347

View: 8334 Download: 122 Web of Science: 16 Crossref: 15

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee

Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.267

View: 7778 Download: 61 Web of Science: 4 Crossref: 5

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort

Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park

Clin Mol Hepatol. 2014;20(3):261-266. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.261

View: 9115 Download: 78 Web of Science: 13 Crossref: 10

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6161 Download: 61 Crossref: 6

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho

Clin Mol Hepatol. 2013;19(3):300-304. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.300

View: 7299 Download: 78 Crossref: 27

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2013;19(3):273-279. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.273

View: 6333 Download: 40 Crossref: 1

Review

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Hyung Joon Yim, Seong Gyu Hwang

Clin Mol Hepatol. 2013;19(3):195-209. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.195

View: 11548 Download: 69 Crossref: 24

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2012;18(2):109-162. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.109

View: 15102 Download: 108 Crossref: 118

Original Article

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun

Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.261

View: 6332 Download: 49 Crossref: 10

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea

Sang Ho Lee, Hyoung Su Kim, Kwon Oh Park, Jong Won Park, Seung Yeon Chun, Seung Jin Lim, Hyun Jung Cho, Sung Jun Kim, Hye Won Park, Han Kook Moon, Woon Geon Shin, Kyung Ho Kim, Myoung Kuk Jang, Jin Heon Lee, Hak Yang Kim

Clin Mol Hepatol. 2010;16(4):362-368. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.362

View: 7187 Download: 38 Crossref: 8

The Korean Journal of Hepatology Elsewhere

Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B

Jeong Won Jang

Clin Mol Hepatol. 2010;16(3):342-346. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.342

View: 5821 Download: 58 Crossref: 1

1

Predictors for virologic response in management of chronic hepatitis B

Jung Min Lee, M.D. Sang Hoon Ahn, M.D.-

Clin Mol Hepatol. 2010;16(1):1-4. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.1

View: 4091 Download: 27

7

The Korean Journal Of Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients

Ji Hoon Kim

Clin Mol Hepatol. 2009;15(3):383-390. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.383

View: 3665 Download: 15

3

Efficacy of 48-week clevudine therapy for chronic hepatitis B

Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.

Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.331

View: 4741 Download: 23 Crossref: 8

1 | 2 | 3 | 4 |

Viewed By 5424	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5394	MAFLD: How is it different from NAFLD?
Viewed By 5287	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3949	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3940	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search